Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

588
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
588
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

152
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
152
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

153
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
153
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

137
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
137
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

64
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
64
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel hypertension phenotypes based on cross-classification of 24-h brachial and aortic SBP.

Journal of hypertension·2026
Same author

Central vs. peripheral access samplings in hemodialysis patients induce variations in parathyroid hormone levels.

Clinical kidney journal·2026
Same author

Subclinical Primary Aldosteronism and eGFR Decline Over Time.

Journal of the American Society of Nephrology : JASN·2026
Same author

Assessing vascular health by measuring arterial stiffness in response to hemodynamic load.

Journal of hypertension·2026
Same author

A mixed-methods protocol to explore psychological distress and psychosocial needs along the continuum of CKD care- a single healthcare network.

BMC nephrology·2025
Same author

Prediction of cardiovascular events by algorithm- and formula-based pulse wave velocity.

Journal of hypertension·2025
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026
Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
See all related articles

Related Experiment Video

Updated: Nov 8, 2025

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

16.2K

Coagulation anomalies, endothelial dysfunction, and aortic stiffness.

Mohsen Agharazii1

  • 1CHU de Québec Research Center, Québec City, Québec, Canada; Division of Nephrology, Department of Medicine, Faculty of Medicine, Université Laval, Québec City, Québec, Canada.

Kidney International
|April 24, 2021
PubMed
Summary
This summary is machine-generated.

Chronic kidney disease causes aortic stiffness due to arterial remodeling. In hemodialysis patients, coagulation activity correlates with this stiffness, despite increased anticoagulant factors and bleeding risk.

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.6K
Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

10.8K

Related Experiment Videos

Last Updated: Nov 8, 2025

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

16.2K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.6K
Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

10.8K

Area of Science:

  • Cardiovascular Science
  • Nephrology
  • Vascular Biology

Background:

  • Chronic kidney disease (CKD) is linked to arterial wall remodeling, resulting in aortic stiffness.
  • Aortic stiffness increases cardiac workload and pulse pressure, potentially causing microvascular damage and organ dysfunction.
  • Endothelial cells are crucial for vascular tone and hemostasis, influencing coagulation and bleeding risk.

Purpose of the Study:

  • To investigate the relationship between coagulation activity and aortic stiffness in hemodialysis patients.
  • To explore the balance of procoagulant and anticoagulant factors in this patient population.

Main Methods:

  • The study by Tran et al. examined coagulation activity in hemodialysis patients.
  • Aortic stiffness was assessed in relation to markers of coagulation.
  • Levels of anticoagulant factors were measured.

Main Results:

  • Ongoing coagulation activity was found to be associated with aortic stiffness in hemodialysis patients.
  • Anticoagulant factors were elevated in these patients.
  • The combination of these factors explained reduced endogenous thrombin potential and increased bleeding risk.

Conclusions:

  • Coagulation activity is linked to aortic stiffness in hemodialysis patients.
  • An imbalance favoring anticoagulation contributes to reduced thrombin generation and heightened bleeding risk.
  • Understanding these vascular and coagulation dynamics is vital for managing CKD complications.